Objective: To determine the efficacy and tolerability of low-dose tamsulosin 0.2 mg/day in Chinese patients with symptomatic benign prostatic hyperplasia (BPH). Conclusions: Low-dose tamsulosin 0. ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback